| Cheplapharm Schweiz GmbH - Sequase 300 mg, Filmtabletten | | 62331 | | 04 | | Sequase 300 mg | | Filmtabletten | | N05AH04 | | Quetiapine | | 01.09.2011 | | |
| | Composition | | quetiapinum 300 mg ut quetiapini fumaras, povidonum K 30, calcii hydrogenophosphas dihydricus, cellulosum microcristallinum, lactosum monohydricum 62.1 mg, carboxymethylamylum natricum A, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, pro compresso obducto corresp. natrium max. 2.268 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Quetiapine | 300 mg |
| | BAG: Active Agent | Dose |
|---|
| Quetiapine | 300 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Calcium Hydrogen Phosphate Dihydrate | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 62.1 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
| |
| |
|
